Xiaodong Zai1, Qiaoling Yang1, Kun Liu1, Ruihua Li1, Mengying Qian1, Taoran Zhao1, Yaohui Li1, Ying Yin1, Dayong Dong1, Ling Fu1, Shanhu Li1, Junjie Xu2, Wei Chen3. 1. Laboratory of Vaccine and Antibody Engineering, Beijing Institute of Biotechnology, Beijing, China. 2. Laboratory of Vaccine and Antibody Engineering, Beijing Institute of Biotechnology, Beijing, China. xujunjie@sina.com. 3. Laboratory of Vaccine and Antibody Engineering, Beijing Institute of Biotechnology, Beijing, China. cw0226@foxmail.com.
Abstract
BACKGROUND: Brucella spp. are Gram-negative, facultative intracellular pathogens that cause brucellosis in both humans and animals. The B. abortus vaccine strain 104 M is the only vaccine available in China for the prevention of brucellosis in humans. Although the B. abortus 104 M genome has been fully sequenced, the current genome annotations are not yet complete. In addition, the main mechanisms underpinning its residual toxicity and vaccine-induced immune protection have yet to be elucidated. Mapping the proteome of B. abortus 104 M will help to improve genome annotation quality, thereby facilitating a greater understanding of its biology. RESULTS: In this study, we utilized a proteogenomic approach that combined subcellular fractionation and peptide fractionation to perform a whole-proteome analysis and genome reannotation of B. abortus 104 M using high-resolution mass spectrometry. In total, 1,729 proteins (56.3% of 3,072) including 218 hypothetical proteins were identified using the culture conditions that were employed this study. The annotations of the B. abortus 104 M genome were also refined following identification and validation by reverse transcription-PCR. In addition, 14 pivotal virulence factors and 17 known protective antigens known to be involved in residual toxicity and immune protection were confirmed at the protein level following induction by the 104 M vaccine. Moreover, a further insight into the cell biology of multichromosomal bacteria was obtained following the elucidation of differences in protein expression levels between the small and large chromosomes. CONCLUSIONS: The work presented in this report used a proteogenomic approach to perform whole-proteome analysis and genome reannotation in B. abortus 104 M; this work helped to improve genome annotation quality. Our analysis of virulence factors, protective antigens and other protein effectors provided the basis for further research to elucidate the mechanisms of residual toxicity and immune protection induced by the 104 M vaccine. Finally, the potential link between replication dynamics, gene function, and protein expression levels in this multichromosomal bacterium was detailed.
BACKGROUND:Brucellaspp. are Gram-negative, facultative intracellular pathogens that cause brucellosis in both humans and animals. The B. abortus vaccine strain 104 M is the only vaccine available in China for the prevention of brucellosis in humans. Although the B. abortus 104 M genome has been fully sequenced, the current genome annotations are not yet complete. In addition, the main mechanisms underpinning its residual toxicity and vaccine-induced immune protection have yet to be elucidated. Mapping the proteome of B. abortus 104 M will help to improve genome annotation quality, thereby facilitating a greater understanding of its biology. RESULTS: In this study, we utilized a proteogenomic approach that combined subcellular fractionation and peptide fractionation to perform a whole-proteome analysis and genome reannotation of B. abortus 104 M using high-resolution mass spectrometry. In total, 1,729 proteins (56.3% of 3,072) including 218 hypothetical proteins were identified using the culture conditions that were employed this study. The annotations of the B. abortus 104 M genome were also refined following identification and validation by reverse transcription-PCR. In addition, 14 pivotal virulence factors and 17 known protective antigens known to be involved in residual toxicity and immune protection were confirmed at the protein level following induction by the 104 M vaccine. Moreover, a further insight into the cell biology of multichromosomal bacteria was obtained following the elucidation of differences in protein expression levels between the small and large chromosomes. CONCLUSIONS: The work presented in this report used a proteogenomic approach to perform whole-proteome analysis and genome reannotation in B. abortus 104 M; this work helped to improve genome annotation quality. Our analysis of virulence factors, protective antigens and other protein effectors provided the basis for further research to elucidate the mechanisms of residual toxicity and immune protection induced by the 104 M vaccine. Finally, the potential link between replication dynamics, gene function, and protein expression levels in this multichromosomal bacterium was detailed.
Authors: Vidya L Atluri; Mariana N Xavier; Maarten F de Jong; Andreas B den Hartigh; Renée M Tsolis Journal: Annu Rev Microbiol Date: 2011 Impact factor: 15.500
Authors: Michel Eschenbrenner; Troy A Horn; Mary Ann Wagner; Cesar V Mujer; Tabbi L Miller-Scandle; Vito G DelVecchio Journal: J Proteome Res Date: 2006-07 Impact factor: 4.466
Authors: Elena S Peterson; Lee Ann McCue; Alexandra C Schrimpe-Rutledge; Jeffrey L Jensen; Hyunjoo Walker; Markus A Kobold; Samantha R Webb; Samuel H Payne; Charles Ansong; Joshua N Adkins; William R Cannon; Bobbie-Jo M Webb-Robertson Journal: BMC Genomics Date: 2012-04-05 Impact factor: 3.969
Authors: Juan Antonio Vizcaíno; Attila Csordas; Noemi del-Toro; José A Dianes; Johannes Griss; Ilias Lavidas; Gerhard Mayer; Yasset Perez-Riverol; Florian Reisinger; Tobias Ternent; Qing-Wei Xu; Rui Wang; Henning Hermjakob Journal: Nucleic Acids Res Date: 2015-11-02 Impact factor: 16.971
Authors: Jayaseelan Murugaiyan; Murat Eravci; Christoph Weise; Uwe Roesler; Lisa D Sprague; Heinrich Neubauer; Gamal Wareth Journal: Biomolecules Date: 2020-05-30